Eloxx Pharmaceuticals' Series C - III Round

Eloxx Pharmaceuticals raised a round of funding on August 02, 2017.

Eloxx Pharmaceuticals (NASDAQ:ELOX) is a clinical stage company developing therapeutics for genetic diseases caused by non-sense mutations.…

Articles about Eloxx Pharmaceuticals' Series C - III Round: